ZIMLAB.NS

Healthcare Drug Manufacturers - Specialty & Generic

ZIM Laboratories Limited

₹150.47

+9.94 +7.07% today

Price History

Not enough data

Key Stats

Market Cap

8.07B

Avg Volume

105,519

P/E (TTM)

183.50

EPS

₹0.82

52W High

₹153.94

52W Low

₹59.31

Div. Yield

0.0%

Valuation

P/B Ratio

2.72

P/S Ratio

2.03

EV/EBITDA

38.85

EV/Revenue

2.19

Margins

Gross Margin 53.0%

Operating Margin (3.1%)

Net Margin 0.9%

EBITDA Margin 5.6%

Growth & Returns

Revenue Growth (YoY)

31.2%

Liquidity & Leverage

Debt / Equity

0.43

Total Cash

402.52M

Total Debt

1.27B

About

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was founded in 1984 and is based in Nagpur, India.